SVAS BIOSANA SPA (SVS.MI) Stock Price, Forecast & Analysis
Europe - Euronext Milan - BIT:SVS - IT0005469264 - Common Stock
SVS.MI Key Statistics, Chart & Performance
The current stock price of SVS.MI is 8.48 EUR. In the past month the price increased by 3.67%.
SVS.MI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1EL.MI | ESSILORLUXOTTICA | 44.51 | 141.63B | ||
| ESL.DE | ESSILORLUXOTTICA | 44.82 | 142.60B | ||
| EL.PA | ESSILORLUXOTTICA | 44.54 | 141.72B | ||
| GBT.PA | GUERBET | 28.39 | 218.92M | ||
| ALCJ.PA | CROSSJECT | N/A | 120.95M | ||
| AFME.PA | AFFLUENT MEDICAL SA | N/A | 59.81M | ||
| PTP.DE | PENTIXAPHARM HOLDING AG | N/A | 34.17M |
Related stock screener links
About SVS.MI
Company Profile
Svas Biosana SpA engages in distributing medical appliances. The company is headquartered in Somma Vesuviana, Napoli and currently employs 350 full-time employees. The company went IPO on 2021-12-09. The firm has two core businesses, namely industrial core and sales core. Industrial core focuses on production and marketing of medical devices, consisting of Farmex and Medical business lines. Sales core is dedicated to trading and distribution of medical devices, consisting of the SVAS and Mark Medical business lines. Farmex is focused on the production and sale of incontinence aids, traditional dressings, cotton wool and products for personal care. Medical business line focuses on production and sale of operating packs, medical devices for infusion and aspiration, linen, advanced dressings and lubricating gel for urology. SVAS is dedicated to selling specialist medical devices for medicine and surgery. Mark Medical is focused on selling medical devices. The firm operates globally.
Company Info
SVAS BIOSANA SPA
Via Trentola, 7
Somma Vesuviana NAPOLI IT
Employees: 327
Phone: 390818995411
SVAS BIOSANA SPA / SVS.MI FAQ
What does SVAS BIOSANA SPA do?
Svas Biosana SpA engages in distributing medical appliances. The company is headquartered in Somma Vesuviana, Napoli and currently employs 350 full-time employees. The company went IPO on 2021-12-09. The firm has two core businesses, namely industrial core and sales core. Industrial core focuses on production and marketing of medical devices, consisting of Farmex and Medical business lines. Sales core is dedicated to trading and distribution of medical devices, consisting of the SVAS and Mark Medical business lines. Farmex is focused on the production and sale of incontinence aids, traditional dressings, cotton wool and products for personal care. Medical business line focuses on production and sale of operating packs, medical devices for infusion and aspiration, linen, advanced dressings and lubricating gel for urology. SVAS is dedicated to selling specialist medical devices for medicine and surgery. Mark Medical is focused on selling medical devices. The firm operates globally.
What is the stock price of SVAS BIOSANA SPA today?
The current stock price of SVS.MI is 8.48 EUR. The price increased by 2.17% in the last trading session.
Does SVAS BIOSANA SPA pay dividends?
SVAS BIOSANA SPA (SVS.MI) has a dividend yield of 2.97%. The yearly dividend amount is currently 0.3.
How is the ChartMill rating for SVAS BIOSANA SPA?
SVS.MI has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
How is the valuation of SVAS BIOSANA SPA (SVS.MI) based on its PE ratio?
The PE ratio for SVAS BIOSANA SPA (SVS.MI) is 6.68. This is based on the reported non-GAAP earnings per share of 1.27 and the current share price of 8.48 EUR.
What is the market capitalization of SVS stock?
SVAS BIOSANA SPA (SVS.MI) has a market capitalization of 47.49M EUR. This makes SVS.MI a Nano Cap stock.
SVS.MI Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to SVS.MI.
SVS.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to SVS.MI. Both the profitability and the financial health of SVS.MI get a neutral evaluation. Nothing too spectacular is happening here.
SVS.MI Financial Highlights
Over the last trailing twelve months SVS.MI reported a non-GAAP Earnings per Share(EPS) of 1.27. The EPS increased by 24.41% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 5.09% | ||
| ROA | 3.75% | ||
| ROE | 10.43% | ||
| Debt/Equity | 0.62 |
SVS.MI Forecast & Estimates
6 analysts have analysed SVS.MI and the average price target is 15.05 EUR. This implies a price increase of 77.42% is expected in the next year compared to the current price of 8.48.
For the next year, analysts expect an EPS growth of 33.33% and a revenue growth 19.23% for SVS.MI